Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A - Coyle, T E; Reding, M T; Lin, J C; Michaels, L A; Shah, A; Powell, J (J Thromb Haemost, 2014)